Chairman & CEO Kenneth Frazier Cashes About $1.56 Million In Equity Value (Pre-Tax)

In an SEC Form 4 just filed, we learn that in addition to his over $24 million in 2015 regular pay, the Merck Chairman & CEO has exercised and sold a bolus of his March 2008 stock options (or the underlying stock, on the NYSE) — netting (pre-tax) about $1.562 million. Not. Too. Shabby.

These sales occured in the markets today, and were conducted under his personal pre-arranged trading plan on file with the SEC. [That in turn means Mr. Frazier did not precisely pick the timing of the sale, only the general (formulaic) trigger points.]

Significantly, even after this latest transaction, he still holds well over half a million common shares of Merck, outright, and has fully vested options on more than an additional 2.6 million shares, and partially unvested options on another 1.2 million or so. So. . . he is still very heavily invested in Merck.

Just employing common sense here, I am all but certain his Merck stockholdings are his single largest asset class, by an order of magnitude — in his personal portfolio. He is — and remains — deeply engaged and aligned with Merck stockholders, in my view. Now you know — out for a walk-about, now. . . Be excellent to one another!


There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: